Breast cancer in Sub-Saharan African women: Review;Le cancer du sein chez la femme de l'Afrique sub-saharienne: État actuel des connaissances

Bulletin du Cancer

Volumn 98, Issue 7, 2011, Pages 797-806

  Ly, Madani ^a,b   Antoine, Martine ^b   André, Fabrice ^c   Callard, Patrice ^b   Bernaudin, Jean François ^b   Diallo, Dapa A ^a  

^a CHU du Point G   (Mali)

^b HÔPITAL TENON   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Breast cancer; Hormonal receptors; Sub Saharan Africa; Triple negative; Women

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR;

AFRICA; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER STAGING; DEVELOPED COUNTRY; HUMAN; INTRADUCTAL CARCINOMA; PROGNOSIS; REVIEW;

EID: 79960550164     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1392     Document Type: Review

References (57)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005 ; 55 : 10-30.
2. Hill C, Doyon F. La fréquence des cancers en France en 2002 et son évolution depuis 1968. Bull Cancer 2006 ; 93 : 7-11.
3. International agency for research on cancer (IARC) : GLOBOCAN, 2002 database. http:www-dep.iarc.fr.
4. Murray E. The management of breast cancer in Africa. A review of the problems presented by breast cancer in Africa. In : Ly A, Khayat D, eds. About cancer in Africa. Institut national du cancer 1 vol, 2006 : 27-41.
5. Echimane AK, Ahnoux AA, Adoubi I, et al. Cancer incidence in Abibjan, Ivory Coast : first results from the cancer registry,1995-1997. Cancer 2000 ; 89 : 653-63.
6. Chokunonga E, Levy LM, Bassett MT, Mauchaza BG, Thomas DB, Parkin DM. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer 2000 ; 85 : 54-9.
7. Nalwoga H, Arnes JB,Wabinga H, Akslen LA. Expression of EGFR and c-kit is associated wthith the basal-like phenotype in breast carcinomas of African women. APMIS 2008 ; 116 : 515-25.
8. Gakwaya A, Kigula-Mugambe JB, Kavuma A, et al. Cancer of the breast: 5-year survival in a tertiary hospital in Unganda. Br J Cancer 2008 ; 99 : 63-7. (Pubitemid 351920233)
9. Ihekwaba FN. Breast cancer in Nigerian women. Br J Surg 1992 ; 79 : 771-5.
10. Anyanwu SNC. Breast cancer in eastern Nigeria: a ten year review. WAJM 2000 ; 19 : 120-5.
11. Ikpatt OF, Kuopio T, Ndoma-Egba R, Collan Y. Breast cancer in Nigeria and Finland: epidemiological, clinical and histological comparison. Anticancer Res 2002 ; 22 : 3005-12. (Pubitemid 36069350)
12. Adesunkanmi ARK, Lawal OO, Adelusola KA, Durosimi MA. The severity, outcome and challenges of breast cancer in Nigeria. The Breast 2006 ; 15 : 399-409. (Pubitemid 43812214)
13. Gukas ID, Jennings BA, Mandong BM, Manasseh AN, Harvey I, Leinster SJ. A comparison of the pattern of occurrence of breast cancer in Nigerian and British women. The Breast 2006 ; 15 : 90-5. (Pubitemid 43210555)
14. UKwenya AY, Yusufu LM, Nmadu PT, Garba ES, Ahmed ES. Delayed treatment of symptomatic breast cancer: the experience from Kaduna, Nigeria. S Afr J Surg 2008 ; 46 : 106-10.
15. Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009 ; 27 : 4515-21.
16. Amir H, Kitinya JN, Parkin DM. A comparative study of carcinoma of the breast in an African population. East Afr Med J 1994 ; 7 : 215-8.
17. Mbonde MP, Amir H, Schwartz-albiez R, Akslen LA, Kitinya JM. Expression of estrogen and progesterone receptors in carcinomas of the female breast in Tanzania. Oncol Rep 2000 ; 7 : 277-883.
18. Othieno-Abinya NA, Nyabola LO, Abwao HO, Ndege P. Postsurgical management of patients with breast cancer at Kenyatta National Hospital. East Afr Med J 2002 ; 79 : 156-62.
19. Nyagol J, Nyong'o A, Byakika B, et al. Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer. Anal Quant Cytol Histol 2006 ; 28 : 97-103.
20. Bird PA, Hill AG, Houssami N. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol 2008 ; 15 : 1983-8.
21. Awadelkarim KD, Arizzi C, Elamin EOM, et al. Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology 2008 ; 52 : 445-56. (Pubitemid 351327981)
22. Sarré B, Ogougbémy M, Dotou C, et al. Aspects épidémiologique, thérapeutique et pronostique des cancers du sein : à propos de 473 cas colligés à l'hôpital principal de Dakar. Dakar Med 2006 ; 51 : 92-6.
23. Yarney J, Vanderpuye V, Clegg Lamptey JN. Hormone receptor and HER-2 expression in breast cancers among Sub-Saharan African Women. Breast J 2008 ; 14 : 510-1.
24. Ly M, Diop S, Sacko M, Baby M, Diop CT, Diallo DA. Cancer du sein : facteurs influençant l'itinéraire thérapeutique des usagers d'un service d'oncologie médicale à Bamako (Mali). Bull Cancer 2002 ; 89 : 323-6. (Pubitemid 34297842)
25. Yawitch TM, Van Rensburg EJ. Absence of commonly recurring BRCA1 mutations in black South African women with breast cancer. S Afr Med J 2000 ; 90 : 788.
26. Muthuphei MN. Carcinoma of the breast at the Ga-Rankuwa hospital histopathology laboratory (South Africa). Cent Afr J Med 1994 ; 40 : 254-7.
27. Awadelkarim KD, Aceto G, Veschi S, et al. BRCA1 and BRCA2 status in a central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat 2007 ; 102 : 189-99. (Pubitemid 46452165)
28. Gao Q, Adebamowo CA, Fackental J, et al. Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer. Hum Genet 2000 ; 107 : 192-4.
29. Wasserman LJ, Apffelstaedt JP, Odendaal JdeV. Conservative management of breast cancer in the elderly in a developing country. World J Surg Oncol 2007 ; 5 : 108.
30. Adebamowo CA, Adekunle OO. Case-controlled study of the epidemiological risk factors for breast cancer in Nigeria. Br J Surg 1999 ; 86 : 665-8. (Pubitemid 29248362)
31. Hoffman M, De Pinho H, Cooper D, et al. Breast cancer incidence and determinants of cancer stage in the western Cape. S Afr Med J 2000 ; 90 : 1212-6. (Pubitemid 32124190)
32. Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 2008 ; 110 : 183-8. (Pubitemid 351793859)
33. Fregene A, Newman LA. Breast cancer in Sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer 2005 ; 103 : 1540-50.
34. Gueye SMK, Bawa KDD, Ba MG, Mendes V, Toure CT, Moreau JC. Dépistage du cancer du sein : connaissance et pratique de l'autoexamen des seins au sein d'une population féminine au Sénégal. Rev Med Brux 2009 ; 30 : 77-82.
35. Huo D, Adebamowa CA, Ogundiran TO, et al. Parity and breastfeeding are protective against breast cancer in Nigerian women. B J Cancer 2008 ; 98 : 992-6. (Pubitemid 351341620)
36. Rosenberg L, Kelly JP, Shapiro S. Risk factors for breast cancer in South African women. S Afr Med J 2002 ; 92 : 447-8. (Pubitemid 34716588)
37. Coogan PF, Rosenberg L, Shapiro S, Hoffman M. Lactation and breast carcinoma risk in a South African population. Cancer 1999 ; 86 : 982-9. (Pubitemid 29439852)
38. Adebamowa CA, Ogundiran TO, Adenipekun AA, et al. Obesity and height in urban Nigerian women with breast cancer. Ann epidemiol 2003 ; 13 : 455-61. (Pubitemid 36870815)
39. Fackenthal JD, Sveen L, Gao Q, et al. Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients. J Med Genet 2005 ; 42 : 271-81.
40. Osime OC, Okojie O, Aigbekaen ET, Aigbekaen IJ. Knowledge attitude and practice about breast cancer among civil servants in Benin city, Nigeria. Ann Afr Med 2008 ; 7 : 192-7.
41. Apffelstaedt JP, Steenkamp V, Baatjes K. Performance data of screening mammography at a dedicated breast health centre. S Afr Med J 2008 ; 98 : 950-3.
42. Flynn MB, Amin EA, Martin RC2nd. Mobile mammography screening: the James Graham Brown Cancer Center three year experience. Implications for public and professional education. J Ky Med Assoc 1998 ; 96 : 17-20.
43. Peek ME, Han J. Mobile mammography: assessment of selfreferral in reaching medically underserved women. J Natl Med Assoc 2007 ; 99 : 398-403. (Pubitemid 46608865)
44. Okonofua FE, Iribhogbe P. Prevention of breast cancer in African women. Afr J Reprod Health 2006 ; 10 : 7-12.
45. Ly M, Valent A, Diallo G, et al. Genomic Profiling of breast cancer in Mali by oligonucleotide comparative genomic hybridization(CGH) array. 32nd Annual San Antonio Breast Cancer Symposuim 2009 Abstract 3059.
46. Cancers du sein : recommandations pour la pratique clinique de Saint Paul de Vence. Oncologie 2007 ; 9 : 593-644.
47. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000 ; 406 : 747-52.
48. Sotirou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003 ; 100 : 10393-8. (Pubitemid 37071889)
49. Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. The Breast Journal 2009 ; 15 : 593-602.
50. Linn SC, Van't Veer LJ. Clinical relevance of the triple-negative breast cancer concept: genetic basis and clinical utility of the concept. Eur J Cancer 2009 ; 45 : 11-26.
51. André F, Job B, Dessen P, et al. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 2009 ; 15 : 441-51.
52. Amir H, Kwesigabo G, Aziz MR, Kitinya JN. Breast cancer and conservative surgery in Sub Saharan Africa. East Afr Med J 1996 ; 73 : 83-7. (Pubitemid 126354119)
53. Menashe I, Anderson WF, Jatoi I, Rosenberg PS. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst 2009 ; 101 : 993-1000.
54. Polite NB, Cirrincione C, Fleming GF, et al. Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840-Cancer and Leukemia Group B. J Clin Oncol 2008 ; 26 : 2659-65.
55. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Co-morbidity and survival disparities among black and white patients with breast cancer. JAMA 2005 ; 294 : 1765-72. (Pubitemid 41434622)
56. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and White American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 2006 ; 24 : 1342-9. (Pubitemid 46621996)
57. Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 2008 ; 100 : 1643-8.